RecruitingNCT06558487

The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model

The Internal Prospective validatiON of a prediCtiOn Model for the Change of admIssion for Patient With caNcer Admitted to the emerGency Department (ONCOMING Study)


Sponsor

Erasmus Medical Center

Enrollment

200 participants

Start Date

Dec 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
  • Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.

Exclusion Criteria3

  • <18 years old
  • Only received a surgical intervention as cancer treatment
  • Admitted to the ED for the surgical department

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCancer Admission Score Prediction Model

A prediction model that calculates the chance for a patient to be admitted after triage and after first blood results


Locations(1)

Erasmus University Medical Center

Rotterdam, South Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06558487


Related Trials